teclistamab
janssen,genmab
['mmsm', 'majestec-1', 'multiplemyeloma', 'teclistamab']
nct04557098: phase 2- teclistamab, in participants with relapsed or refractory myeloma (majestec-1)
#mmsm #multiplemyeloma #eha2022 
Multiple Myeloma Education Platform for Myeloma Community